IL97740A - Oral rehydration solution containing rice dextrin and a process for its preparation - Google Patents

Oral rehydration solution containing rice dextrin and a process for its preparation

Info

Publication number: IL97740A
Authority: IL; Israel
Prior art keywords: rice; glucose; dextrin; ors; rice dextrin
Prior art date: 1990-04-03

Application number

IL9774091A

Other languages

English (en)

Other versions

IL97740A0 (en

Original Assignee

Bristol Myers Squibb Co

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1990-04-03

Filing date

1991-04-01

Publication date

1995-03-15

1991-04-01 Application filed by Bristol Myers Squibb Co filed Critical Bristol Myers Squibb Co

1992-06-21 Publication of IL97740A0 publication Critical patent/IL97740A0/xx

1995-03-15 Publication of IL97740A publication Critical patent/IL97740A/en

Links

235000007164 Oryza sativa Nutrition 0.000 title claims abstract description 151
235000009566 rice Nutrition 0.000 title claims abstract description 151
229920001353 Dextrin Polymers 0.000 title claims abstract description 106
239000004375 Dextrin Substances 0.000 title claims abstract description 106
235000019425 dextrin Nutrition 0.000 title claims abstract description 106
239000000310 rehydration solution Substances 0.000 title claims abstract description 22
238000000034 method Methods 0.000 title claims abstract description 17
230000008569 process Effects 0.000 title claims abstract description 14
238000002360 preparation method Methods 0.000 title description 4
240000007594 Oryza sativa Species 0.000 title 1
241000209094 Oryza Species 0.000 claims abstract description 150
WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims abstract description 103
239000008103 glucose Substances 0.000 claims abstract description 103
235000013312 flour Nutrition 0.000 claims abstract description 26
229920000642 polymer Polymers 0.000 claims abstract description 25
238000001914 filtration Methods 0.000 claims abstract description 23
OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 claims abstract description 16
239000003792 electrolyte Substances 0.000 claims abstract description 7
150000001720 carbohydrates Chemical class 0.000 claims description 27
239000000706 filtrate Substances 0.000 claims description 14
125000002791 glucosyl group Chemical group C1([C@H](O)[C@@H](O)[C@H](O)[C@H](O1)CO)* 0.000 claims description 11
239000007921 spray Substances 0.000 claims description 5
230000007071 enzymatic hydrolysis Effects 0.000 claims description 3
238000006047 enzymatic hydrolysis reaction Methods 0.000 claims description 3
230000007935 neutral effect Effects 0.000 claims description 2
239000000243 solution Substances 0.000 abstract description 36
FYGDTMLNYKFZSV-MRCIVHHJSA-N dextrin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)OC1O[C@@H]1[C@@H](CO)OC(O[C@@H]2[C@H](O[C@H](O)[C@H](O)[C@H]2O)CO)[C@H](O)[C@H]1O FYGDTMLNYKFZSV-MRCIVHHJSA-N 0.000 abstract description 25
239000000203 mixture Substances 0.000 abstract description 16
206010012735 Diarrhoea Diseases 0.000 abstract description 15
208000019902 chronic diarrheal disease Diseases 0.000 abstract description 4
235000014633 carbohydrates Nutrition 0.000 description 24
108010028144 alpha-Glucosidases Proteins 0.000 description 23
102000016679 alpha-Glucosidases Human genes 0.000 description 23
239000011734 sodium Substances 0.000 description 23
108010065511 Amylases Proteins 0.000 description 21
102000013142 Amylases Human genes 0.000 description 21
DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 21
229910052708 sodium Inorganic materials 0.000 description 21
235000019418 amylase Nutrition 0.000 description 19
239000004382 Amylase Substances 0.000 description 18
XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 18
230000029087 digestion Effects 0.000 description 17
ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 14
229960003975 potassium Drugs 0.000 description 14
229910052700 potassium Inorganic materials 0.000 description 14
239000011591 potassium Substances 0.000 description 14
239000000047 product Substances 0.000 description 12
210000002966 serum Anatomy 0.000 description 12
239000007787 solid Substances 0.000 description 12
239000012530 fluid Substances 0.000 description 11
239000000758 substrate Substances 0.000 description 10
208000005156 Dehydration Diseases 0.000 description 9
230000018044 dehydration Effects 0.000 description 9
238000006297 dehydration reaction Methods 0.000 description 9
239000000796 flavoring agent Substances 0.000 description 9
238000011534 incubation Methods 0.000 description 9
102000004169 proteins and genes Human genes 0.000 description 9
108090000623 proteins and genes Proteins 0.000 description 9
235000019634 flavors Nutrition 0.000 description 8
VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 7
KRKNYBCHXYNGOX-UHFFFAOYSA-K Citrate Chemical compound [O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O KRKNYBCHXYNGOX-UHFFFAOYSA-K 0.000 description 7
102000004190 Enzymes Human genes 0.000 description 7
108090000790 Enzymes Proteins 0.000 description 7
229940088598 enzyme Drugs 0.000 description 7
238000010438 heat treatment Methods 0.000 description 7
238000004519 manufacturing process Methods 0.000 description 7
239000000843 powder Substances 0.000 description 7
240000008042 Zea mays Species 0.000 description 6
235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 6
235000002017 Zea mays subsp mays Nutrition 0.000 description 6
238000005352 clarification Methods 0.000 description 6
235000005822 corn Nutrition 0.000 description 6
238000009826 distribution Methods 0.000 description 6
230000000694 effects Effects 0.000 description 6
238000009472 formulation Methods 0.000 description 6
210000001035 gastrointestinal tract Anatomy 0.000 description 6
238000002671 oral rehydration therapy Methods 0.000 description 6
239000006188 syrup Substances 0.000 description 6
235000020357 syrup Nutrition 0.000 description 6
BVKZGUZCCUSVTD-UHFFFAOYSA-M Bicarbonate Chemical compound OC([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-M 0.000 description 5
229920002245 Dextrose equivalent Polymers 0.000 description 5
241000209140 Triticum Species 0.000 description 5
235000021307 Triticum Nutrition 0.000 description 5
230000000968 intestinal effect Effects 0.000 description 5
108010073178 Glucan 1,4-alpha-Glucosidase Proteins 0.000 description 4
102100022624 Glucoamylase Human genes 0.000 description 4
230000007062 hydrolysis Effects 0.000 description 4
238000006460 hydrolysis reaction Methods 0.000 description 4
238000000338 in vitro Methods 0.000 description 4
238000012360 testing method Methods 0.000 description 4
QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 3
JVTAAEKCZFNVCJ-UHFFFAOYSA-M Lactate Chemical compound CC(O)C([O-])=O JVTAAEKCZFNVCJ-UHFFFAOYSA-M 0.000 description 3
201000009840 acute diarrhea Diseases 0.000 description 3
230000001154 acute effect Effects 0.000 description 3
235000021257 carbohydrate digestion Nutrition 0.000 description 3
KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
230000006735 deficit Effects 0.000 description 3
230000002183 duodenal effect Effects 0.000 description 3
239000008151 electrolyte solution Substances 0.000 description 3
238000005187 foaming Methods 0.000 description 3
230000036571 hydration Effects 0.000 description 3
238000006703 hydration reaction Methods 0.000 description 3
238000005259 measurement Methods 0.000 description 3
239000013618 particulate matter Substances 0.000 description 3
239000002244 precipitate Substances 0.000 description 3
230000004044 response Effects 0.000 description 3
235000021023 sodium intake Nutrition 0.000 description 3
230000001954 sterilising effect Effects 0.000 description 3
238000004659 sterilization and disinfection Methods 0.000 description 3
238000002560 therapeutic procedure Methods 0.000 description 3
210000002700 urine Anatomy 0.000 description 3
OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 description 2
DBTMGCOVALSLOR-UHFFFAOYSA-N 32-alpha-galactosyl-3-alpha-galactosyl-galactose Natural products OC1C(O)C(O)C(CO)OC1OC1C(O)C(OC2C(C(CO)OC(O)C2O)O)OC(CO)C1O DBTMGCOVALSLOR-UHFFFAOYSA-N 0.000 description 2
RXVWSYJTUUKTEA-UHFFFAOYSA-N D-maltotriose Natural products OC1C(O)C(OC(C(O)CO)C(O)C(O)C=O)OC(CO)C1OC1C(O)C(O)C(O)C(CO)O1 RXVWSYJTUUKTEA-UHFFFAOYSA-N 0.000 description 2
GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 description 2
VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 2
FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
229920002472 Starch Polymers 0.000 description 2
XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 2
206010047700 Vomiting Diseases 0.000 description 2
238000003556 assay Methods 0.000 description 2
WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 2
238000009835 boiling Methods 0.000 description 2
230000015556 catabolic process Effects 0.000 description 2
230000000052 comparative effect Effects 0.000 description 2
DDRJAANPRJIHGJ-UHFFFAOYSA-N creatinine Chemical compound CN1CC(=O)NC1=N DDRJAANPRJIHGJ-UHFFFAOYSA-N 0.000 description 2
239000013078 crystal Substances 0.000 description 2
238000011156 evaluation Methods 0.000 description 2
239000011521 glass Substances 0.000 description 2
230000009229 glucose formation Effects 0.000 description 2
230000036541 health Effects 0.000 description 2
208000015181 infectious disease Diseases 0.000 description 2
239000004615 ingredient Substances 0.000 description 2
239000002198 insoluble material Substances 0.000 description 2
238000012423 maintenance Methods 0.000 description 2
FYGDTMLNYKFZSV-UHFFFAOYSA-N mannotriose Natural products OC1C(O)C(O)C(CO)OC1OC1C(CO)OC(OC2C(OC(O)C(O)C2O)CO)C(O)C1O FYGDTMLNYKFZSV-UHFFFAOYSA-N 0.000 description 2
238000002156 mixing Methods 0.000 description 2
230000008520 organization Effects 0.000 description 2
230000002265 prevention Effects 0.000 description 2
238000012545 processing Methods 0.000 description 2
239000008213 purified water Substances 0.000 description 2
210000003296 saliva Anatomy 0.000 description 2
239000013049 sediment Substances 0.000 description 2
235000019698 starch Nutrition 0.000 description 2
239000008107 starch Substances 0.000 description 2
230000000007 visual effect Effects 0.000 description 2
FYGDTMLNYKFZSV-BYLHFPJWSA-N β-1,4-galactotrioside Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@H](CO)O[C@@H](O[C@@H]2[C@@H](O[C@@H](O)[C@H](O)[C@H]2O)CO)[C@H](O)[C@H]1O FYGDTMLNYKFZSV-BYLHFPJWSA-N 0.000 description 2
YKXCWZVUWWQSAV-BTVCFUMJSA-N (2r,3s,4r,5r)-2,3,4,5,6-pentahydroxyhexanal;sodium Chemical compound [Na].OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C=O YKXCWZVUWWQSAV-BTVCFUMJSA-N 0.000 description 1
101100243025 Arabidopsis thaliana PCO2 gene Proteins 0.000 description 1
208000035473 Communicable disease Diseases 0.000 description 1
108010001394 Disaccharidases Proteins 0.000 description 1
241000588724 Escherichia coli Species 0.000 description 1
238000008458 Glucose Oxidase Reagent Methods 0.000 description 1
102000003939 Membrane transport proteins Human genes 0.000 description 1
108090000301 Membrane transport proteins Proteins 0.000 description 1
CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
229930006000 Sucrose Natural products 0.000 description 1
241000607626 Vibrio cholerae Species 0.000 description 1
238000002835 absorbance Methods 0.000 description 1
238000010521 absorption reaction Methods 0.000 description 1
229940025131 amylases Drugs 0.000 description 1
238000000540 analysis of variance Methods 0.000 description 1
238000004458 analytical method Methods 0.000 description 1
150000001450 anions Chemical class 0.000 description 1
230000015572 biosynthetic process Effects 0.000 description 1
210000004369 blood Anatomy 0.000 description 1
239000008280 blood Substances 0.000 description 1
239000006227 byproduct Substances 0.000 description 1
239000004202 carbamide Substances 0.000 description 1
238000005119 centrifugation Methods 0.000 description 1
238000006243 chemical reaction Methods 0.000 description 1
238000000546 chi-square test Methods 0.000 description 1
235000009508 confectionery Nutrition 0.000 description 1
239000013256 coordination polymer Substances 0.000 description 1
229940109239 creatinine Drugs 0.000 description 1
230000003247 decreasing effect Effects 0.000 description 1
239000008367 deionised water Substances 0.000 description 1
229910021641 deionized water Inorganic materials 0.000 description 1
230000001419 dependent effect Effects 0.000 description 1
230000000994 depressogenic effect Effects 0.000 description 1
238000011161 development Methods 0.000 description 1
238000010586 diagram Methods 0.000 description 1
235000019621 digestibility Nutrition 0.000 description 1
102000038379 digestive enzymes Human genes 0.000 description 1
108091007734 digestive enzymes Proteins 0.000 description 1
150000002016 disaccharides Chemical class 0.000 description 1
201000010099 disease Diseases 0.000 description 1
208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
229940079593 drug Drugs 0.000 description 1
239000003814 drug Substances 0.000 description 1
230000002255 enzymatic effect Effects 0.000 description 1
238000001976 enzyme digestion Methods 0.000 description 1
239000000284 extract Substances 0.000 description 1
235000013305 food Nutrition 0.000 description 1
235000013355 food flavoring agent Nutrition 0.000 description 1
238000005755 formation reaction Methods 0.000 description 1
230000002496 gastric effect Effects 0.000 description 1
150000002303 glucose derivatives Chemical class 0.000 description 1
230000005484 gravity Effects 0.000 description 1
238000004128 high performance liquid chromatography Methods 0.000 description 1
239000012456 homogeneous solution Substances 0.000 description 1
230000002458 infectious effect Effects 0.000 description 1
208000037817 intestinal injury Diseases 0.000 description 1
210000004347 intestinal mucosa Anatomy 0.000 description 1
239000007788 liquid Substances 0.000 description 1
239000012263 liquid product Substances 0.000 description 1
239000000463 material Substances 0.000 description 1
230000009061 membrane transport Effects 0.000 description 1
235000015097 nutrients Nutrition 0.000 description 1
235000003715 nutritional status Nutrition 0.000 description 1
230000003204 osmotic effect Effects 0.000 description 1
238000010979 pH adjustment Methods 0.000 description 1
230000000704 physical effect Effects 0.000 description 1
239000001508 potassium citrate Substances 0.000 description 1
229960002635 potassium citrate Drugs 0.000 description 1
QEEAPRPFLLJWCF-UHFFFAOYSA-K potassium citrate (anhydrous) Chemical compound [K+].[K+].[K+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O QEEAPRPFLLJWCF-UHFFFAOYSA-K 0.000 description 1
235000011082 potassium citrates Nutrition 0.000 description 1
230000001737 promoting effect Effects 0.000 description 1
229940100486 rice starch Drugs 0.000 description 1
239000004576 sand Substances 0.000 description 1
239000011780 sodium chloride Substances 0.000 description 1
239000001509 sodium citrate Substances 0.000 description 1
NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 description 1
238000002798 spectrophotometry method Methods 0.000 description 1
238000003860 storage Methods 0.000 description 1
238000006467 substitution reaction Methods 0.000 description 1
239000005720 sucrose Substances 0.000 description 1
235000000346 sugar Nutrition 0.000 description 1
150000008163 sugars Chemical class 0.000 description 1
239000006228 supernatant Substances 0.000 description 1
208000006379 syphilis Diseases 0.000 description 1
239000008399 tap water Substances 0.000 description 1
235000020679 tap water Nutrition 0.000 description 1
229940118696 vibrio cholerae Drugs 0.000 description 1
230000008673 vomiting Effects 0.000 description 1
230000004584 weight gain Effects 0.000 description 1
235000019786 weight gain Nutrition 0.000 description 1

Classifications

- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
- C08B30/00—Preparation of starch, degraded or non-chemically modified starch, amylose, or amylopectin
- C08B30/12—Degraded, destructured or non-chemically modified starch, e.g. mechanically, enzymatically or by irradiation; Bleaching of starch
- C08B30/18—Dextrin, e.g. yellow canari, white dextrin, amylodextrin or maltodextrin; Methods of depolymerisation, e.g. by irradiation or mechanically
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
- A23L29/30—Foods or foodstuffs containing additives; Preparation or treatment thereof containing carbohydrate syrups; containing sugars; containing sugar alcohols, e.g. xylitol; containing starch hydrolysates, e.g. dextrin
- A23L29/35—Degradation products of starch, e.g. hydrolysates, dextrins; Enzymatically modified starches
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/14—Alkali metal chlorides; Alkaline earth metal chlorides
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/12—Antidiarrhoeals

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Engineering & Computer Science (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Epidemiology (AREA)
Polymers & Plastics (AREA)
Molecular Biology (AREA)
Chemical Kinetics & Catalysis (AREA)
Organic Chemistry (AREA)
Inorganic Chemistry (AREA)
Nutrition Science (AREA)
Materials Engineering (AREA)
Crystallography & Structural Chemistry (AREA)
Biochemistry (AREA)
Food Science & Technology (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Bioinformatics & Cheminformatics (AREA)
General Chemical & Material Sciences (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicines Containing Plant Substances (AREA)
Medicinal Preparation (AREA)
Cereal-Derived Products (AREA)
Coloring Foods And Improving Nutritive Qualities (AREA)

IL9774091A 1990-04-03 1991-04-01 Oral rehydration solution containing rice dextrin and a process for its preparation IL97740A (en)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US07/504,142 US5096894A (en)	1990-04-03	1990-04-03	Rice dextrin oral rehydration solution
SG7895A SG7895G (en)	1990-04-03	1995-01-18	Rice dextrin oral rehydration solution

Publications (2)

Publication Number	Publication Date
IL97740A0 IL97740A0 (en)	1992-06-21
IL97740A true IL97740A (en)	1995-03-15

Family

ID=26663795

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
IL9774091A IL97740A (en)	1990-04-03	1991-04-01	Oral rehydration solution containing rice dextrin and a process for its preparation

Country Status (19)

Country	Link
US (1)	US5096894A (pl)
EP (1)	EP0459108B1 (pl)
JP (1)	JPH0757729B2 (pl)
AT (1)	ATE113443T1 (pl)
AU (1)	AU642483B2 (pl)
CA (1)	CA2039473C (pl)
CY (1)	CY1824A (pl)
DE (1)	DE69104901T2 (pl)
DK (1)	DK0459108T3 (pl)
EG (1)	EG19628A (pl)
ES (1)	ES2062593T3 (pl)
HK (1)	HK52095A (pl)
IL (1)	IL97740A (pl)
MX (1)	MX172924B (pl)
OA (1)	OA09491A (pl)
PL (1)	PL165045B1 (pl)
PT (1)	PT97229B (pl)
SG (1)	SG7895G (pl)
ZA (1)	ZA912423B (pl)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5120539A (en) *	1991-01-22	1992-06-09	Doyle W. Boatwright	Amylase-electrolyte oral rehydration method and composition
US20050181021A1 (en) *	1992-02-14	2005-08-18	Robert Lamb	Vitamin E phosphate/phosphatidycholine liposomes to protect from or ameliorate cell damage
GB9212737D0 (en) *	1992-06-16	1992-07-29	Norbrook Lab	Veterinary product
US5498408A (en) *	1992-09-21	1996-03-12	Sandoz Nutrition Ltd.	Oral rehydration composition
US5869458A (en) *	1994-10-14	1999-02-09	Waite; Christopher S.	Frozen rehydration formulation and delivery system therefor
US5489440A (en) *	1995-03-06	1996-02-06	Abbott Laboratories	Rice flour-based oral rehydration solution
WO1996037206A1 (en) *	1995-05-26	1996-11-28	Virbac Laboratories (Nz) Limited	Rice flour based oral rehydration compositions for farm animals
GB9715340D0 (en) *	1997-07-22	1997-09-24	Cerestar Holding Bv	Beverages for enhanced physical performance
US6572898B2 (en)	1999-05-21	2003-06-03	Pts Labs Llc	Electrolyte gels for maintaining hydration and rehydration
GB0008209D0 (en) *	2000-04-04	2000-05-24	Highnoon Lab Limited	Oral rehydration formulation
US20030194448A1 (en) *	2002-04-16	2003-10-16	Mitchell Cheryl R.	Oral rehydration composition
TWI250572B (en) *	2002-06-03	2006-03-01	Jsr Corp	Polishing pad and multi-layer polishing pad
KR101106509B1 (ko)	2003-03-10	2012-01-20	다니스코 유에스 인크.	선생물적 이소말토-올리고사카라이드를 함유하는 곡물조성물 및 이의 제조 및 이용 방법
US20050008685A1 (en) *	2003-07-07	2005-01-13	Mitchell Cheryl R.	Oral rehydration compositions containing liposomes
US20090029009A1 (en) *	2007-07-24	2009-01-29	St Phard Dimitri	Sports drink containing rice syrup and agave nectar
US20090029010A1 (en) *	2007-07-24	2009-01-29	Ritorna Natural, Inc.	Organic sports drink containing rice syrup and agave nectar
MX2010000660A (es) *	2009-12-11	2011-06-14	Abbott Lab	Soluciones de rehidratacion oral que comprenden dextrosa.
US9717726B2 (en) *	2013-03-14	2017-08-01	Maregade Rx, LLC	Product and method for treating diarrhea
CN110973481A (zh) *	2020-01-04	2020-04-10	广东一家亲营养科技有限公司	一种谷基配方米粉的中温酶解工艺及配方米粉

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
FR1419128A (fr) *	1964-12-14	1965-11-26	Nat Starch Chem Corp	Fond de sauces et procédé pour le préparer
US4120952A (en) *	1975-10-06	1978-10-17	Arizona Feeds	Method for the treatment of diarrhea in monogastric animals
GB1547941A (en) *	1977-03-24	1979-07-04	Gen Foods Corp	Method of making edible acidifield carbohydrate powers
GB8512345D0 (en) *	1985-05-15	1985-06-19	Scras	Anti-diarrhea compositions
US4830861A (en) *	1988-07-14	1989-05-16	Bristol-Myers Company	Low manganese high protein rice flour

1990
- 1990-04-03 US US07/504,142 patent/US5096894A/en not_active Ceased
1991
- 1991-03-28 CA CA002039473A patent/CA2039473C/en not_active Expired - Fee Related
- 1991-04-01 MX MX025182A patent/MX172924B/es unknown
- 1991-04-01 IL IL9774091A patent/IL97740A/en not_active IP Right Cessation
- 1991-04-02 EP EP91105195A patent/EP0459108B1/en not_active Expired - Lifetime
- 1991-04-02 PT PT97229A patent/PT97229B/pt not_active IP Right Cessation
- 1991-04-02 ZA ZA912423A patent/ZA912423B/xx unknown
- 1991-04-02 AU AU73946/91A patent/AU642483B2/en not_active Ceased
- 1991-04-02 OA OA59983A patent/OA09491A/xx unknown
- 1991-04-02 DK DK91105195.1T patent/DK0459108T3/da active
- 1991-04-02 AT AT91105195T patent/ATE113443T1/de not_active IP Right Cessation
- 1991-04-02 ES ES91105195T patent/ES2062593T3/es not_active Expired - Lifetime
- 1991-04-02 DE DE69104901T patent/DE69104901T2/de not_active Expired - Fee Related
- 1991-04-03 PL PL91289725A patent/PL165045B1/pl not_active IP Right Cessation
- 1991-04-03 JP JP3146967A patent/JPH0757729B2/ja not_active Expired - Fee Related
- 1991-04-03 EG EG19691A patent/EG19628A/xx active
1995
- 1995-01-18 SG SG7895A patent/SG7895G/en unknown
- 1995-04-06 HK HK52095A patent/HK52095A/en not_active IP Right Cessation
- 1995-12-01 CY CY182495A patent/CY1824A/xx unknown

Also Published As

Publication number	Publication date
US5096894A (en)	1992-03-17
JPH0757729B2 (ja)	1995-06-21
CY1824A (en)	1995-12-01
AU642483B2 (en)	1993-10-21
SG7895G (en)	1995-06-16
EP0459108A3 (en)	1992-01-08
ES2062593T3 (es)	1994-12-16
HK52095A (en)	1995-04-13
IL97740A0 (en)	1992-06-21
CA2039473C (en)	1997-03-25
MX172924B (es)	1994-01-21
PT97229B (pt)	1998-09-30
DE69104901D1 (de)	1994-12-08
PL289725A1 (en)	1991-11-04
JPH05320054A (ja)	1993-12-03
EG19628A (en)	1995-10-31
OA09491A (fr)	1992-11-15
DK0459108T3 (da)	1994-12-19
EP0459108A2 (en)	1991-12-04
EP0459108B1 (en)	1994-11-02
AU7394691A (en)	1991-10-10
PL165045B1 (pl)	1994-11-30
ATE113443T1 (de)	1994-11-15
CA2039473A1 (en)	1991-10-04
DE69104901T2 (de)	1995-03-30
PT97229A (pt)	1992-01-31
ZA912423B (en)	1991-12-24

Legal Events

Date	Code	Title
1997-07-13	KB	Patent renewed
2001-07-24	KB	Patent renewed
2005-07-25	KB	Patent renewed
2009-09-15	KB	Patent renewed
2011-12-29	EXP	Patent expired

Publication	Publication Date	Title
US5096894A (en)	1992-03-17	Rice dextrin oral rehydration solution
KR0181312B1 (ko)	1999-02-01	정장작용을 갖는 식품조성물
EP0470895B1 (en)	1995-12-06	Food composition having hypotensive effect
JPH07170938A (ja)	1995-07-11	食品にビフィズス菌の増殖促進作用を付与する方法
EP1088832A1 (en)	2001-04-04	Highly resistant granular starch
BG107094A (bg)	2003-05-30	Въглехидратна система и метод за осигуряване на хранене при диабетици
KR20010013449A (ko)	2001-02-26	알파-아밀라제에 대해 내성을 가지는 식품급 전분
JP2639726B2 (ja)	1997-08-13	水溶性食物繊維およびその製造法
JPH0349650A (ja)	1991-03-04	可溶性米蛋白質濃厚物
JPH0767368B2 (ja)	1995-07-26	調合乳およびその調製法
JP5363006B2 (ja)	2013-12-11	架橋反応
US5519011A (en)	1996-05-21	Food composite performing function of improving serum lipid
MX2007003210A (es)	2009-02-16	Composicion de almidon tolerante al proceso con alto contenido de fibra dietetica total.
JP2006502103A (ja)	2006-01-19	縮合パラチノース及びその製造方法
JP2938471B2 (ja)	1999-08-23	水溶性食物繊維含有飲食品
USRE36032E (en)	1999-01-05	Rice dextrin oral rehydration solution
Albarracín et al.	2016	Extruded whole grain diets based on brown, soaked and germinated rice. Effects on cecum health, calcium absorption and bone parameters of growing Wistar rats. Part I
JPH0965836A (ja)	1997-03-11	α−グルコシダーゼ阻害剤、それを含む糖組成物、甘味料、食品及び飼料
US5120539A (en)	1992-06-09	Amylase-electrolyte oral rehydration method and composition
JP2670742B2 (ja)	1997-10-29	α−アミラーゼ阻害物質
US5523086A (en)	1996-06-04	Method for manufacturing a health food utilizing a garlic
US20240306681A1 (en)	2024-09-19	Method for flash heat treatment of pea starch
JPH092963A (ja)	1997-01-07	マオウより得られる糖質分解酵素阻害物質及びそれを含有するダイエット食品
WO2007072756A1 (ja)	2007-06-28	ミネラル吸収促進剤、食品及び飼料
EP1043022B1 (en)	2007-07-11	Sodium ion absorption inhibitors and sodium ion excretion accelerators as preventive and therapeutic agents for diseases resulting from excessive intake of common salt